A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Irinotecan; Oxaliplatin; Rigosertib
- Indications Solid tumours
- Focus Adverse reactions
- 13 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jun 2010 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.